Patients Navigators in Facilitating Weight Management in Obese Participants
NCT ID: NCT03674229
Last Updated: 2025-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
171 participants
INTERVENTIONAL
2015-07-02
2030-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Piloting a Patient Navigator Program for Weight Loss
NCT06972381
Telecoaching Plus a Portion Control Device for Weight Management in the Primary Care Setting
NCT02373878
PATH to Health: An Exploration of Digital Behavioral Weight Loss Approaches
NCT05929469
Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss
NCT05180448
Partnership Optimizes Weight Management in Primary Care
NCT02959021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To evaluate the effectiveness of patient navigators to increase enrollment in evidence-based weight management programs.
SECONDARY OBJECTIVES:
I. To evaluate the effectiveness of patient navigators to increase overall attendance or use of evidence-based weight management programs.
II. To evaluate the effectiveness of patient navigators to promoting and facilitating positive health behavior change: increased physical activity; improved diet; and weight loss.
OUTLINE: Participants are randomized to 1 of 2 groups.
GROUP I: Participants receive information about commercially-available weight management programs and encouragement to participate in one of the programs for 6 months.
GROUP II: Participants receive information about commercially-available weight management programs encouragement to participate in one of the programs for 6 months. Participants also receive 6 phone calls over 20-30 minutes each from an assigned patient navigator for 6 months.
After completion of the study, participants are followed up at 2 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (information about weight management programs)
Participants receive information about commercially-available weight management programs and encouragement to participate in one of the programs for 6 months.
Informational Intervention
Receive information about weight management programs
Questionnaire Administration
Ancillary studies
Group II (information, call from patient navigator)
Participants receive information about commercially-available weight management programs encouragement to participate in one of the programs for 6 months. Participants also receive 6 phone calls over 20-30 minutes each from an assigned patient navigator for 6 months.
Informational Intervention
Receive information about weight management programs
Questionnaire Administration
Ancillary studies
Telephone-Based Intervention
Receive phone calls from an assigned patient navigator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Informational Intervention
Receive information about weight management programs
Questionnaire Administration
Ancillary studies
Telephone-Based Intervention
Receive phone calls from an assigned patient navigator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a body mass index (BMI) greater than or equal to 30 and less than or equal to 45 kg/m\^2
* Are able to read and speak English
* Have a working telephone number and address where materials can be mailed
* Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q)
* Internet access at home or other location (e.g., work, church, library, community center, etc.)
Exclusion Criteria
* Pregnant or thinking about becoming pregnant during the study period
* Are already involved in another weight loss program
* Participated in a weight loss, exercise, or dietary modification program in the previous 6 months
* Involuntary or voluntary weight loss of greater than or equal to 5% body weight in the previous 6 months
* Are currently using weight loss medications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lorna McNeill
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Heredia NI, Fernandez ME, van den Berg AE, Durand CP, Kohl HW, Reininger BM, Hwang KO, McNeill LH. Coaction Between Physical Activity and Fruit and Vegetable Intake in Racially Diverse, Obese Adults. Am J Health Promot. 2020 Mar;34(3):238-246. doi: 10.1177/0890117119884479. Epub 2019 Nov 13.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-01819
Identifier Type: OTHER
Identifier Source: secondary_id
2015-0255
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.